Company: FEAV
Filing Date: 2025-01-24
Form Type: PRE 14A
Source: 0000950170-25-008828
Chunk: 24

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-01-24
Form: PRE 14A
Chunk 24
---
 LISTING RULES AND THE ASX LISTING RULES, AND FOR ALL OTHER PURPOSES, (a) THE ISSUANCE OF SHARES OF OUR COMMON STOCK TO THE NOTEHOLDERS UPON EXCHANGE OF ALL OF OUR OUTSTANDING NOTES, AND (b)(i)the issuance and sale to the Noteholders of $5.0 million of Common Stock at the price per share described BELOW and(ii)the issuance to the Noteholders of warrants to purchase UP TO $20.0 million of Common Stock at the exercise price described BELOW

As part of the out-of-court process, we will issue the following securities, subject to our stockholders approving this Proposal:

pursuant to the Exchange Agreement, the issuance of 312,490,076 shares of our Common Stock to the Noteholders in the Exchange;

pursuant to the Subscription Agreement, the issuance and sale by us of $5.0 million of Common Stock to the Noteholders at a price per share equal to the Subscription Price; and

pursuant to the Subscription Agreement, the issuance by us to the Noteholders of the Warrants to purchase a number of shares of Common Stock represented by up to $20.0 million divided by the Subscription Price, at a price per share equal to the Subscription Price.

If this Proposal and the Equity Plan Proposal are approved by our stockholders and each of the other conditions in the Restructuring Support Agreement is either satisfied or waived as provided for therein, the transactions contemplated by the Exchange Agreement, the Subscription Agreement and the Registration Rights Agreement will occur.

Our Common Stock is listed on the Nasdaq Global Select Market and our CDIs are listed on the ASX, and, as such, we are subject to Nasdaq Listing Rules, including Nasdaq Listing Rule 5635, and the ASX Listing Rules.

Pursuant to Nasdaq Listing Rule 5635(d), stockholder approval is required prior to the issuance of securities in a transaction, other than a public offering, involving the sale, issuance or potential issuance by the Company of Common Stock (or securities convertible into or exercisable for Common Stock), which equals 20% or more of the Common Stock or 20% or more of the voting power outstanding before the issuance, at a price less than the lower of: (i) the closing price immediately preceding the signing of the binding agreement or (ii) the average closing price of the Common Stock for the five trading days immediately preceding the signing of the binding agreement for the transaction.

The issuance of